Two Different NF1 Pathogenic Variants in a Family With Neurofibromatosis Type 1
- PMID: 39730180
- PMCID: PMC11696324
- DOI: 10.21873/cgp.20485
Two Different NF1 Pathogenic Variants in a Family With Neurofibromatosis Type 1
Abstract
Background/aim: Neurofibromatosis type 1 (NF1) is a genetic disorder with an incidence of approximately one in 3,000. More than half of the patients have new de novo pathogenic variants of the NF1 gene. In most family cases, all family members share an identical NF1-variant. The aim of the study was to investigate the very rare phenomenon of de novo variants in cases of familial neurofibromatosis type 1 and highlight its implications for genetic testing and counseling.
Patients and methods: Patients underwent clinical examination in our NF outpatient clinic and genetic testing for the NF1-gene was performed by targeted sequencing. All family members were profiled by short-tandem repeat marker analysis. Additionally, a probability calculation was performed for this extremely rare event.
Results: In one NF1 family consisting of mother, father, and two sons, two different pathogenic variants of the NF1 gene were found. The father and one son share one NF1-variant and the other son carries a different de novo NF1-variant. Neither of these two NF1-variants was found in the unaffected mother. Short-tandem repeat analysis confirmed the paternity and revealed that the two sons inherited two different NF1-alleles from their father. The probability of two different NF1-variants occurring in one family is calculated as 1:9,000,000.
Conclusion: Two different NF1-variants in one family is an extremely rare phenomenon: yet its occurrence is not impossible and therefore should be considered in genetic diagnosis and counselling. For an offspring with the indication for neurofibromatosis type 1, but lacking the familial pathogenic variant, a screening of the whole NF1-gene is necessary to detect potential new pathogenic variants and for exact diagnosis.
Keywords: NF1; Neurofibromatosis type 1; de novo pathogenic variant; familial transmission; independent variants.
Copyright © 2025, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Conflict of interest statement
None to declare.
Similar articles
-
Neurofibromatosis type 1 families with first-degree relatives harbouring distinct NF1 pathogenic variants. Genetic counselling and familial diagnosis: what should be offered?J Med Genet. 2022 Oct;59(10):1017-1023. doi: 10.1136/jmedgenet-2021-108301. Epub 2022 Feb 4. J Med Genet. 2022. PMID: 35121649
-
Novel, heterozygous, de novo pathogenic variant (c.4963delA: p.Thr1656Glnfs*42) of the NF1 gene in a Chinese family with neurofibromatosis type 1.BMC Med Genomics. 2023 Apr 24;16(1):85. doi: 10.1186/s12920-023-01514-x. BMC Med Genomics. 2023. PMID: 37095468 Free PMC article.
-
Five novel NF1 gene pathogenic variants in 10 different Chinese families with neurofibromatosis type 1.Mol Genet Genomic Med. 2019 Sep;7(9):e904. doi: 10.1002/mgg3.904. Epub 2019 Jul 25. Mol Genet Genomic Med. 2019. PMID: 31347283 Free PMC article. Clinical Trial.
-
NF1 mutations and molecular testing.J Child Neurol. 2002 Aug;17(8):555-61; discussion 571-2, 646-51. doi: 10.1177/088307380201700803. J Child Neurol. 2002. PMID: 12403553 Review.
-
Spinal neurofibromatosis with NF1 mutation in a classic neurofibromatosis type 1 family: A case report and literature review.Mol Genet Genomic Med. 2020 Jan;8(1):e1035. doi: 10.1002/mgg3.1035. Epub 2019 Nov 11. Mol Genet Genomic Med. 2020. PMID: 31713330 Free PMC article. Review.
References
-
- Carey JC, Viskochil DH. Neurofibromatosis type 1: A model condition for the study of the molecular basis of variable expressivity in human disorders. Am J Med Genet. 1999;89(1):7–13. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous